Literature DB >> 19944314

Clinical impact of dyslipidemia for coronary plaque vulnerability in acute coronary syndrome without metabolic syndrome.

Masaya Kato1, Keigo Dote, Shota Sasaki, Kentaro Ueda, Yasuyuki Kono, Toru Naganuma, Yoshikazu Watanabe, Masato Kajikawa, Haruko Yokoyama, Akifumi Higashi.   

Abstract

BACKGROUND: Although the metabolic syndrome is associated with incident cardiovascular disease, low-density lipoprotein (LDL) cholesterol is a well-known risk factor for coronary atherosclerosis. The aim of this study was to clarify the clinical markers for coronary plaque vulnerability in acute coronary syndrome (ACS) patients (men) without the metabolic syndrome.
METHODS: Consecutive Japanese men with ACS (n=264) underwent emergent coronary angiography and B-mode carotid ultrasonography. Common carotid intima-media thickening and vascular dilatation were considered to indicate carotid artery remodeling. Patients were divided into two groups based on the number of complex plaques identified by coronary angiography.
RESULTS: Abdominal obesity and low high-density lipoprotein cholesterol levels were frequently observed in overall patients with multiple complex coronary lesions. Although the metabolic syndrome was a significant independent predictor of multiple complex coronary lesions in overall ACS patients, a high LDL cholesterol level was an independent predictor in ACS patients without the metabolic syndrome. Carotid artery remodeling was an independent predictor of multiple complex coronary lesions in both overall patients and patients without the metabolic syndrome.
CONCLUSION: In ACS patients without the metabolic syndrome, high LDL cholesterol levels and carotid artery remodeling are important indicators for assessing the efficacy of aggressive treatments for secondary prevention of ACS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19944314     DOI: 10.1016/j.jjcc.2009.06.007

Source DB:  PubMed          Journal:  J Cardiol        ISSN: 0914-5087            Impact factor:   3.159


  2 in total

1.  Statin therapy/lipid lowering therapy among Indian adults with first acute coronary event: The dyslipidemia Residual and Mixed Abnormalities IN spite of Statin therapy (REMAINS) study.

Authors:  Salgaonkar V Jaywant; A K Singh; Mundkur S Prabhu; R Ranjan
Journal:  Indian Heart J       Date:  2016-02-28

2.  The effects of treatment on lipoprotein subfractions evaluated by polyacrylamide gel electrophoresis in patients with autoimmune hypothyroidism and hyperthyroidism.

Authors:  Zuzana Minarikova; Ludovit Gaspar; Peter Kruzliak; Zuzana Celecová; Stanislav Oravec
Journal:  Lipids Health Dis       Date:  2014-10-10       Impact factor: 3.876

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.